Quantcast

Latest UCLA's Jonsson Comprehensive Cancer Center Stories

2010-08-25 07:55:00

PHILADELPHIA, Aug. 25 /PRNewswire/ -- In celebration of a seminal discovery in cancer biology, Fox Chase Cancer Center will host the Philadelphia Chromosome Symposium: Past, Present and Future, on September 28, 2010, from 8 a.m. to 7 p.m. at The Chemical Heritage Foundation, 315 Chestnut Street, Philadelphia. The event marks the 50th anniversary of the discovery of the first genetic abnormality associated with cancer, and the first to lead to a targeted therapy for cancer. The symposium...

2010-08-18 06:00:00

BAJA, California, Mexico, Aug. 18 /PRNewswire/ -- The International Cancer Care Foundation (ICCF) has launched a new 'house call' program designed to bring the worlds most cutting edge cancer treatments to your home. According to the foundation medical director Antonio Jimenez, M.D., staff physicians partner with local doctors to treat patients in their own country. ICCF will send members of their medical staff to Canada, Europe, the United Kingdom, Africa, Thailand, Philippines, Saudi...

4d88a55a288c1ed75bbd2b2a8fccda5e1
2010-08-08 21:01:18

Researchers at UCLA's Jonsson Comprehensive Cancer Center and the departments of Chemistry and Biochemistry and Pathology and Laboratory Medicine have uncovered a role for an essential cell protein in shuttling RNA into the mitochondria, the energy-producing "power plant" of the cell.The import of nucleus-encoded small RNAs into mitochondria is essential for the replication, transcription and translation of the mitochondrial genome, but the mechanisms that deliver RNA into mitochondria remain...

2010-08-05 09:26:00

CRANBURY, N.J., Aug. 5 /PRNewswire/ -- Cornerstone Pharmaceuticals, Inc. today announced the addition of Mary Crowley Cancer Research Centers to its roster of sites for its ongoing Phase I/II clinical trials of its first-in-class anti-cancer agent, CPI-613. Cornerstone is a leader in the discovery and development of cancer therapies that capitalize upon and disrupt the unique metabolic processes of cancer cells. "As one of the national pioneers in early phase clinical trials, the Mary...

481e98013422ee81f964573253643cd5
2010-08-04 08:45:00

Technology marks advance toward predictive and personalized medicine New technologies for the diagnosis of cancer are rapidly changing the clinical practice of oncology. As scientists learn more about the molecular basis of cancer, the development of new tools capable of multiple, inexpensive biomarker measurements on small samples of clinical tissue will become essential to the success of genetically informed and personalized cancer therapies. Researchers at UCLA have now developed a...

2010-07-23 13:15:30

Study finds that the GRB7 gene drives an aggressive form of the disease Oregon Health & Science University Knight Cancer Institute researchers found that the GRB7 gene drives an aggressive form of breast cancer and acts independently of the HER-2 gene, known to be a stimulator of breast cancer growth. Isolating the role of this gene could ultimately help fine-tune a patient's treatment and enable physicians to provide a more accurate prognosis. The study, published online this month by...

2010-07-16 14:10:00

LOS ANGELES, July 16 /PRNewswire-USNewswire/ -- Ronald Reagan UCLA Medical Center ranks as one of the top five American hospitals -- and the best hospital in the western United States for the 21st consecutive year -- according to a U.S. News & World Report survey that reviewed patient-outcomes data, reputation among physicians and other care-related factors. "We put the patient at the core of everything we do -- that's the ultimate standard," said Dr. David Feinberg, CEO and associate...

2010-07-09 13:55:00

Findings hold important implications for cancer therapy The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected. Such targeted-therapy methods would represent a major advance over current chemotherapy, in which anticancer drugs are distributed throughout the body, attacking...

2010-06-25 13:35:52

A large scale genetic analysis of multiple prostate cancer samples, published online by Cell Press on June 24th in the journal Cancer Cell, is providing exciting new insight into the disease and may lead to more effective treatment strategies. In addition, the freely available genetic and clinical outcome data obtained in the study represents a valuable public resource for the cancer research community. Prostate cancer is clinically diverse with some patients developing fatal metastatic...

2010-05-11 09:00:00

INDIANAPOLIS, LOS ANGELES, SOUTH SAN FRANCISCO and WASHINGTON, May 11 /PRNewswire/ -- Cancer patients and doctors are finally getting on the same page about cancer survivorship, thanks to a free new tool that can benefit anyone who has been diagnosed with cancer. Journey Forward (www.JourneyForward.org), has released a new computer-based tool that enables anyone diagnosed with any type of cancer to have their medical history, cancer treatment summary and a post-treatment survivorship...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.